EX-99.3 3 drr0417_ex99-3.htm EXHIBIT 99.3

 

Exhibit 99.3

 

 

Dr. Reddy’s Laboratories Ltd.

8-2-337, Road No. 3, Banjara Hills,

Hyderabad - 500 034, Telangana,
India.

CIN : L85195TG1984PLC004507  

 

Tel      : +91 40 4900 2900

Fax     : +91 40 4900 2999

Email : mail@drreddys.com

www.drreddys.com

 

Date: July 30, 2022

 

To,

The Secretary/Executive Director

BSE Limited

National Stock Exchange of India Limited

New York Stock Exchange, Inc.

NSE-IFSC Limited

 

Dear Sir/Madam,

 

Sub: Copies of newspaper advertisement regarding unaudited financial results for the quarter ended June 30, 2022

 

Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015, as amended, please find enclosed copies of newspaper advertisement regarding the unaudited financial results of the company for the quarter ended June 30, 2022, as published in Business Standard and Andhra Prabha on July 28, 2022.

 

This is for your information and records

 

Thanking you.

 

Yours faithfully,

For Dr. Reddy’s Laboratories Limited

 

 

/s/ K Randhir Singh    
K Randhir Singh    
Company Secretary & Compliance Officer    

 

Encl: as above